Study to Assess Medication Satisfaction in Patients With Relapsing Remitting Multiple Sclerosis Treated With Copaxone®

NCT02499900 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

861

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Copaxone®

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.